• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Emerging Technologies Fostering Biotech Innovation Globally

Monday, June 03, 2024
Breakout Session
Emerging Opportunities in Global Markets
26B
This session explores the transformative role that cutting-edge pharmaceutical technologies play in fostering biotech innovation on a global scale. We will debate examples of how breakthroughs from mRNA technology beyond vaccines to CRISPR-Cas9 gene editing are reshaping drug development, tailoring treatments to individual patients, and driving the pharmaceutical industry. Attendees will gain insights into how AI algorithms are accelerating drug discovery, optimizing clinical trial designs, and predicting drug candidates with remarkable precision. The session will also discuss the bioprocessing revolution, highlighting the role of automation, robotics, and data analytics in enhancing manufacturing, increasing efficiency but also ensuring product quality, reducing costs, and promoting sustainability.
Moderator
Falk Ehmann, MD, PhD
Head of Innovation and Development Accelerator (IDeA)
European Medicines Agency (EMA)
Speakers
Blythe Adamson, PhD, MPH
Senior Principal Scientist, Head of Outcomes Research
Flatiron Health
Lesley Maloney, PharmD
Global Regulatory Policy Lead for Digital Health
Genentech, Inc., A Member of the Roche Group
Irene Norstedt, MSc
Director, DG Research and Innovation
European Commission
Vivek Thakkar
Biologics Consulting
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS